美国药品专利领域反向支付的反托拉斯问题

    Applying Antitrust Law to Reverse Payments about Drug Patent in the United States

    • 摘要: 反向支付主要发生在美国药品领域,由专利权人向通用名药申请人支付巨额费用而换取被控侵权人保持在药品市场之外。美国巡回上诉法院在对反向支付适用反托拉斯法时有3种态度,第1种是严格适用本身违法原则,第2种是适用专利范围测试而予以反托拉斯责任的豁免,第3种是适用合理原则。最近,美国最高法院对此问题进行表态,要求适用合理原则。考虑到美国药品专利领域反向支付反托拉斯案件的特点,作为借鉴,中国在制定相关法律法规时应考虑激励创新、竞争秩序和人道主义等因素。

       

      Abstract: Reverse payments mainly appear in drug patent field of United States. It means that a patentee pays large amounts of money to a generic drug applicant, also in most cases an accused infringer, so that the accused infringer stay out of the drug market. The Circuit Appeal Courts of United States have three attitudes on applying antitrust law to reverse payment: the first is applying strict per se rule, the second is the scope of the patent test which exempts the antitrust responsibility of reverse payment, and the third is applying rule of reason. Recently, the Supreme Court of United States declared its attitude on this problem which called for the application of the rule of reason. In view of the reverse payment antitrust cases in America as references, we should consider the factors of stimulating innovation, competition order and humanitarianism when we formulate relevant laws and rules.

       

    /

    返回文章
    返回
    Baidu
    map